English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1988]
News [3223]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
Elderly population needs new definition to inform treatment decisions
Dr Reinhard Stauder, Prof Mario Boccadoro
Elderly population needs new definition to inform treatment decisions ( Dr Reinhard Stauder, Prof Mario Boccadoro )
27 Nov 2013
Expert care is needed for elderly haematology patients
Prof Matti Aapro, Dr Lodovico Balducci, Prof Mario Boccadoro, Prof Anders...
Expert care is needed for elderly haematology patients ( Prof Matti Aapro, Dr Lodovico Balducci, Prof Mario Boccadoro, Prof Anders Österborg )
27 Nov 2013
Aiding treatment of HIV and cancer with aspirin
Dr Andrew Freedman - National Cancer Institute, Bethesda, USA
Aiding treatment of HIV and cancer with aspirin ( Dr Andrew Freedman - National Cancer Institute, Bethesda, USA )
27 Nov 2013
ISIS 2 study: Use of aspirin to prevent cardiovascular problems
Dr Conrad Keating - University of Oxford, UK
ISIS 2 study: Use of aspirin to prevent cardiovascular problems ( Dr Conrad Keating - University of Oxford, UK )
27 Nov 2013
Engineering of polymeric nanoparticles for medical applications
Dr Omid Farokhzad - Harvard Medical School, Boston, USA
Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )
14 Nov 2013
The future of CLL treatment: balancing efficacy, safety and cost
Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA
The future of CLL treatment: balancing efficacy, safety and cost ( Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA )
14 Nov 2013
Making sense of the expanding armoury of treatment options for the less fit CLL...
Dr Valentin Goede - Uniklinik Köln, Cologne, Germany
Making sense of the expanding armoury of treatment options for the less fit CLL patient ( Dr Valentin Goede - Uniklinik Köln, Cologne, Germany )
14 Nov 2013
‘Go-Go’ CLL patients: a look towards the future
Professor Clemens Wendtner - Klinikum Schwabing, Munich, Germany
‘Go-Go’ CLL patients: a look towards the future ( Professor Clemens Wendtner - Klinikum Schwabing, Munich, Germany )
14 Nov 2013
The economic burden of CLL treatment now and in the future
Dr George Follows - Addenbrooke’s Hospital, Cambridge, UK
The economic burden of CLL treatment now and in the future ( Dr George Follows - Addenbrooke’s Hospital, Cambridge, UK )
14 Nov 2013
The future of CLL treatment: Balancing efficacy, safety, and cost: Introduction...
Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA
The future of CLL treatment: Balancing efficacy, safety, and cost: Introduction from the Chair ( Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA )
10 Nov 2013
Making sense of the expanding armoury of treatment options for the less fit...
Dr Valentin Goede - Uniklinik Köln, Cologne, Germany
Making sense of the expanding armoury of treatment options for the less fit patient ( Dr Valentin Goede - Uniklinik Köln, Cologne, Germany )
10 Nov 2013
Genomic test to guide breast cancer treatment decisions approved in UK
Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK
Genomic test to guide breast cancer treatment decisions approved in UK ( Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK )
31 Oct 2013
<1...131132133134135...166>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top